Financial News
Headline News about Exelixis Inc
![](https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_6692.png?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022
November 01, 2022
Via Benzinga
![](https://g.foolcdn.com/editorial/images/706031/bear-market-stocks-plunge-crash-invest-correction-getty.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/09/08/aapharma_13.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_604.png?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/706113/cancer-patient-flexing-muscle.jpg)
![](https://g.foolcdn.com/editorial/images/704941/a-family-meeting-with-an-advisor.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_5803.png?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For October 18, 2022
October 18, 2022
Via Benzinga
![](https://www.investors.com/wp-content/uploads/2021/06/Stock-Exelixis-01-shutt.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/06/16/aapharma_7.png?width=1200&height=800&fit=crop)
Exelixis-BioInvent Establish Immuno-Oncology Pact
June 16, 2022
Via Benzinga
![](https://g.foolcdn.com/editorial/images/704469/plants-on-coins.jpeg)
![](https://investorplace.com/wp-content/uploads/2021/11/shutterstock_1667119063.png)
![](https://investorplace.com/wp-content/uploads/2021/03/biotech-stocks-2.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/09/12/aapharma_3.png?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2017/08/HTI-WALLSTREET-adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/08/09/biotech7.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/12/shutterstock_1726134715.png)
![](https://investorplace.com/wp-content/uploads/2019/07/biotech1600d.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/07/07/screen_shot_2022-07-07_at_10.02.51_am.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_17039.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/06/21/bz-pharma_3.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/06/16/syringe-ge28143bc6_1920.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-pre-market.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_9034.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_6181.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/05/10/analysis-gea8109339_1920.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/05/03/cells-gdd37bc5d2_1920.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/05/03/aapharma_0.png?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.